Publications dans lesquelles il/elle collabore avec ESTHER MOLINA RIVAS (23)

2024

  1. Influence of BDNF Val66Met genetic polymorphism in Major Depressive Disorder and Body Mass Index: Evidence from a meta-analysis of 6481 individuals

    Journal of Affective Disorders, Vol. 344, pp. 458-465

  2. Mutational landscape of risk variants in comorbid depression and obesity: a next-generation sequencing approach

    Molecular Psychiatry

2022

  1. Body mass index interacts with a genetic-risk score for depression increasing the risk of the disease in high-susceptibility individuals

    Translational Psychiatry, Vol. 12, Núm. 1

  2. Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors

    Biological psychiatry, Vol. 91, Núm. 3, pp. 313-327

  3. Interaction Effect between Physical Activity and the BDNF Val66Met Polymorphism on Depression in Women from the PISMA-ep Study

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 4

  4. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  5. Toxoplasma gondii Seropositivity Interacts with Catechol-O-methyltransferase Val105/158Met Variation Increasing the Risk of Schizophrenia

    Genes, Vol. 13, Núm. 6

2021

  1. Efecto del maltrato en la infancia sobre la depresión y la obesidad en la adultez: Resultados del estudio PISMA-Ep.

    Encuentros en Neurociencias (Universidad de Granada), pp. 249-278

  2. Epidemiology of social phobia in Andalusia

    Revista de Psiquiatria y Salud Mental

2019

  1. Associations of major depressive disorder with chronic physical conditions, obesity and medication use: Results from the PISMA-ep study

    European Psychiatry, Vol. 60, pp. 20-27

  2. Physical exercise and body mass index as correlates of major depressive disorder in community-dwelling adults: Results from the PISMA-ep study

    Journal of Affective Disorders, Vol. 251, pp. 263-269

2018

  1. A Cross-Sectional Study on the Prevalence and Risk Correlates of Mental Disorders: The GRANADΣP Study

    Journal of Nervous and Mental Disease, Vol. 206, Núm. 9, pp. 716-725

2016

  1. Protocolo y metodología del estudio epidemiológico de la salud mental en Andalucía: PISMA-ep

    Revista de Psiquiatria y Salud Mental, Vol. 9, Núm. 4, pp. 185-194

2015

  1. Epidemiological support for genetic variability at hypothalamic-pituitary-adrenal axis and serotonergic system as risk factors for major depression

    Neuropsychiatric Disease and Treatment, Vol. 11, pp. 2743-2754

  2. The risk for major depression conferred by childhood maltreatment is multiplied by BDNF and SERT genetic vulnerability: A replication study

    Journal of Psychiatry and Neuroscience, Vol. 40, Núm. 3, pp. 187-196

2014

  1. Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain

    Schizophrenia Research, Vol. 159, Núm. 1, pp. 107-113

2013

  1. A MAOA gene*cocaine severity interaction on impulsivity and neuropsychological measures of orbitofrontal dysfunction: Preliminary results

    Drug and Alcohol Dependence, Vol. 133, Núm. 1, pp. 287-290

2011

  1. Polymorphic variation at the serotonin 1-A receptor gene is associated with comorbid depression and generalized anxiety

    Psychiatric Genetics, Vol. 21, Núm. 4, pp. 195-201

2009

  1. High-activity variants of the uMAOA polymorphism increase the risk for depression in a large primary care sample

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 150, Núm. 3, pp. 395-402

  2. Variabilidad en el gen COMT y modificación del riesgo de esquizofrenia conferido por consumo de cannabis

    Revista de Psiquiatria y Salud Mental, Vol. 2, Núm. 2, pp. 89-94